The latest announcements, events, and milestones from Evoq Technologies.
The first-time exhibitor is demonstrating a new portable dark adaptation device and making the case for measuring night vision loss complaints in primary eye care.
Read More >EVOQ Technologies announced The Unseen Epidemic, a clinical guide to using functional dark adaptation testing for earlier detection and management of retinal disease.
Read More >If you plan to attend AAOptom in Anaheim, CA this year, we invite you to visit EVOQ Technologies during September 30th to October 3rd at Booth 566 as we exhibit at the meeting for the first time.
Read More >Patent covers a mobile-device-based system that delivers visual stimulation and wirelessly records ocular electrophysiological responses.
Read More >Dr. Hein-Peters takes responsibility for expanding EVOQ Technologies' market presence and driving revenue growth through fundraising, strategic partnerships and product launches.
Read More >LAS VEGAS—(EINPRESSWIRE)—Evoq Technologies (evoqtechnologies.com) today announced a major milestone for eye care, confirming that its innovative diagnostic device, Twilight™, is officially registered and listed with the U.S. Food and Drug Administration (FDA) as a Class I medical device and is now available for sale in the United States.
Read More >